ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Outlook Therapeutics Inc

Outlook Therapeutics Inc (OTLK)

1.99
0.00
(0.00%)
Closed January 27 3:00PM
0.00
0.00
(0.00%)

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000000
Operating Income -15.67M-6.86M-18.15M-12.47M-10.32M-18.97M-19.62M-22.89M
Pre Tax Income -18.66M-6.65M-20.68M-12.99M-11.18M-114.29M44.41M5.69M
Net Income -18.66M-6.65M-20.68M-12.99M-11.18M-114.29M44.41M5.69M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -15.67M-6.86M-21.06M-13.31M-11.31M-27.49M-12.06M-23.4M
EBITDA -15.66M-6.84M-18.14M-12.46M-10.29M-18.94M-19.59M-22.98M
Year End September 29 2024 20172018201920202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 3.81M3.09M8.15M00000
Operating Income -35.88M-29.64M-36.3M-36.84M-51.77M-63.12M-53.14M-71.8M
Pre Tax Income -38.35M-33.74M-37.94M-38.51M-53.16M-66.05M-58.98M-75.36M
Net Income -40.03M-48.02M-36.04M-48.87M-53.16M-66.05M-58.98M-75.37M
Preferred Dividends 00-625k-10.5M0000
Basic Earnings Per Share (EPS) -1.605-0.665-1.26-0.384-0.301-0.291-0.227-3.026
EBIT -35.88M-30.9M-36.91M-36.94M-51.77M-64M-56.89M-74.26M
EBITDA -33.19M-26.59M-21.67M-36.09M-51.61M-62.96M-53.09M-71.8M